COVAX - Time to reconsider the strategy and its target

• Egile Nagusiak: David Bell (Egilea), Garrett W. Brown (Egilea), Wellington A. Oyibo (Egilea), Samiratou Ouédraogo (Egilea), Blagovesta Tacheva (Egilea), Elena Barbaud (Egilea), Andreas Kalk (Egilea), Valéry Ridde (Egilea), Elisabeth Paul (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2023-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

COVAX, the international initiative supporting COVID-19 vaccination campaigns globally, is budgeted to be the costliest public health initiative in low- and middle-income countries, with over 16 billion US dollars already committed. While some claim that the target of vaccinating 70% of people world...